Sumitovant subsidiaries Enzyvant and Altavant merge into combined company
Two Sumitovant Biopharma entities are merging under one name, effective immediately.
Enzyvant Therapeutics and Altavant Sciences announced they have merged to form a singular entity …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.